COVID-19 Pneumonia

• CLINICAL_TRIALS trial_result · 2020-07-07
  Clinical Trial Update: Statistical and Epidemiological Study Based on the Use of Convalescent Plasma for the Management of Patients With COVID-19 [Phase 1, Phase 2]

  Clinical trial update evaluating convalescent plasma for COVID-19 pneumonia in Phase 1/Phase 2; status not disclosed.

• CLINICAL_TRIALS trial_result · 2020-06-09
  Clinical Trial Update: Ozone Auto-hemotherapy for COVID-19 Pneumonia [Phase 3]

  A Phase 3 clinical trial investigating ozone auto-hemotherapy for COVID-19 pneumonia; current status is unknown.

• CLINICAL_TRIALS trial_result · 2020-05-21
  Clinical Trial Update: ACT-20 in Patients With Severe COVID-19 Pneumonia [Phase 1, Phase 2]

  An update on the ACT-20 trial in patients with severe COVID-19 pneumonia across Phase 1 and Phase 2.

• CLINICAL_TRIALS trial_result · 2020-05-06
  Clinical Trial Update: The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation [Phase 4]

  Clinical trial update on using tocilizumab for severe COVID-19 with suspected pulmonary hyperinflammation (Phase 4).

• CLINICAL_TRIALS trial_result · 2020-04-29
  Clinical Trial Update: Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit [Phase 3]

  Phase 3 trial comparing azithromycin plus amoxicillin/clavulanate versus amoxicillin/clavulanate in COVID-19 pneumonia patients not in inten…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2020-04-17
  Clinical Trial Update: Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort [Phase 2]

  Phase 2 trial investigating bevacizumab (Avastin/Zeribev) for efficacy and safety in patients with COVID-19 pneumonia.

• CLINICAL_TRIALS trial_result · 2020-04-15
  Clinical Trial Update: Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort [Phase 2]

  Phase 2 trial evaluating anticoagulation in patients with COVID-19 pneumonia within the Corimmuno-19 cohort; status not disclosed.